Glenn Dranoff - Nanotechnology

Author Information

Glenn Dranoff is a prominent researcher affiliated with the Novartis Institute for Biomedical Research in Cambridge, MA, USA. His extensive work in the field of biomedicine, particularly in cancer immunotherapy, has significantly contributed to the scientific community.

Research Contributions

Glenn Dranoff has made substantial contributions to cancer research, emphasizing immunotherapy and the role of cytokines in cancer treatment. His studies span various topics, including the feasibility of using autologous GM-CSF-secreting breast cancer vaccines, colon stroma's role in inflammation-driven fibroblastic responses, and the potential of SHP2 blockade in enhancing anti-tumor immunity. Dranoff's research has also explored GM-CSF secreting leukemia cell vaccination, the use of IMiD-inducible degrons for chimeric antigen receptor regulation, and several other innovative approaches in cancer immunotherapy. His work is highly influential, as evidenced by his numerous publications and citations.

Aliases

G. Dranoff is also known by several aliases, including G Dranoff, Glen Dranoff, and Glenn Dranoff.

Publication and Citation Metrics

Metric Value
Citation Count 40,535
H-index 92
Paper Count 327

Publications:

DOI: 10.1158/2326-6074.TUMIMM18-A76

Year: 2020

DOI: 10.1158/2326-6074.TUMIMM18-B79

Year: 2020

Partnered Content Networks

Relevant Topics